Literature DB >> 25478391

Triple test in carcinoma breast.

Suman Kharkwal1, Arindam Mukherjee2.   

Abstract

INTRODUCTION: The commonest clinical presentation in majority of breast pathology is a lump. A definite diagnosis of breast lump is very important for the surgeon to decide on the final course of treatment and also saves the patient from unnecessary physical, emotional and psychological trauma if there is a definite preoperative diagnosis of benign lesion. The present study was done to evaluate the effectiveness and relevance of "TRIPLE TEST"in diagnosis of carcinoma breast in rural labour class population.
MATERIALS AND METHODS: The present study was a prospective study conducted on patients over 35 years of age having palpable breast lumps presenting in the out patient department of general surgery, ESI Hospital Basaidarapur New Delhi, India. The duration of study was from May 2007 to June 2009 and a total of 100 cases were studied. Each patient was subjected to a detailed history, clinical breast examination ,diagnostic mammography and FNAC. In this study, the results of each modality was divided in three groups: benign, suspicious and malignant. The sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of each test was calculated individually and as combined. RESULT: Out of 100 patients enrolled in this study, 60 cases were benign and 40 cases were of malignant breast disease. The age of patients with carcinoma breast in the series varied from 35 years to 70 years. The highest incidence of malignancy noted was 30% in 41-50 years age group (4(th) decade) followed by 27.5% in 51-60 years age group (5(th) decade). The sensitivity of clinical examination was found to be 75%, specificity was 83.3%, positive predictive value (PPV) of 75% and diagnostic accuracy of 80%. The sensitivity, specificity, positive predictive value and diagnostic accuracy of mammography was calculated and was found to be 94.9% , 90% , 86% and 92% respectively. The sensitivity, specificity, positive predictive value and diagnostic accuracy of FNAC was 94.7%, 98.3%, 97.3% and 96.6% respectively. Out of 100 cases triple test was concordant (all three test either benign or malignant) in 80 cases, all the benign cases detected by triple test were benign on final biopsy i.e. 100% specificity and 100% negative predictive value.
CONCLUSION: TTS is an accurate and least invasive diagnostic test based on which definitive treatment can be initiated.

Entities:  

Keywords:  Breast lump; Carcinoma breast; Triple test

Year:  2014        PMID: 25478391      PMCID: PMC4253209          DOI: 10.7860/JCDR/2014/9237.4971

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions.

Authors:  P J Westenend; A R Sever; H J Beekman-De Volder; S J Liem
Journal:  Cancer       Date:  2001-04-25       Impact factor: 6.860

Review 2.  [Fine needle aspiration biopsy of breast lesions: institutional experience].

Authors:  Heriberto Medina-Franco; Leonardo Abarca-Pérez; Rubén Cortés-González; Santos Soto-Germes; José A Ulloa; Norma Uribe
Journal:  Rev Invest Clin       Date:  2005 May-Jun       Impact factor: 1.451

3.  Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings.

Authors:  J Vetto; R Pommier; W Schmidt; M Wachtel; P DuBois; M Jones; A Thurmond
Journal:  Am J Surg       Date:  1995-05       Impact factor: 2.565

Review 4.  Fine-needle aspiration biopsy: a review.

Authors:  W J Frable
Journal:  Hum Pathol       Date:  1983-01       Impact factor: 3.466

5.  Usefulness of the triple test score for palpable breast masses; discussion 1012-3.

Authors:  K T Morris; R F Pommier; A Morris; W A Schmidt; G Beagle; P W Alexander; S Toth-Fejel; J Schmidt; J T Vetto
Journal:  Arch Surg       Date:  2001-09

6.  The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How?

Authors:  M B Barton; R Harris; S W Fletcher
Journal:  JAMA       Date:  1999-10-06       Impact factor: 56.272

7.  Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted?

Authors:  Oswald Graf; Thomas H Helbich; Michael H Fuchsjaeger; Gottfried Hopf; Margarita Morgun; Claudia Graf; Reinhold Mallek; Edward A Sickles
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

8.  Profile of breast cancer patients at a tertiary care hospital in north India.

Authors:  D S Sandhu; S Sandhu; R K Karwasra; S Marwah
Journal:  Indian J Cancer       Date:  2010 Jan-Mar       Impact factor: 1.224

9.  Mammographic diagnosis of breast carcinoma: an institutional experience.

Authors:  B Thapa; Y Singh; P Sayami; U Khanal
Journal:  JNMA J Nepal Med Assoc       Date:  2008 Apr-Jun       Impact factor: 0.406

10.  Accuracy of combined clinical-mammographic-cytologic diagnosis of dominant breast masses. A prospective study.

Authors:  J A Butler; H I Vargas; N Worthen; S E Wilson
Journal:  Arch Surg       Date:  1990-07
View more
  5 in total

Review 1.  The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine-Needle Aspiration Biopsy.

Authors:  Ian C Bennett; Apoorva Saboo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Quadruple Score: A Novel Scoring System for Diagnosing Breast Lump - A Retrospective Pilot Study.

Authors:  Swagata Brahmachari; Vikram Vasuniya; Soma Mukherjee; Aditi Chaurasia
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10

3.  A Comparative Study Between Fine-Needle Aspiration Cytology and Core Needle Biopsy in Diagnosing Clinically Palpable Breast Lumps.

Authors:  Kalyani Tripathi; Rita Yadav; Shyam Kumar Maurya
Journal:  Cureus       Date:  2022-08-05

4.  Early detection breast cancer: role of circulating plasma miRNA-21 expression as a potential screening biomarker

Authors:  Muhammad Noor Diansyah; Ami Ashariati Prayogo; Made Putra Sedana; Merlyna Savitri; Pradana Zaky Romadhon; Putu Niken Ayu Amrita; Andi Yasmin Wijaya; Winona May Hendrata; Ugroseno Yudho Bintoro
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

5.  Cost-effectiveness of screening for anal cancer using regular digital ano-rectal examinations in men who have sex with men living with HIV.

Authors:  Jason J Ong; Christopher K Fairley; Susan Carroll; Sandra Walker; Marcus Chen; Tim Read; Andrew Grulich; Catriona Bradshaw; John Kaldor; Philip Clarke
Journal:  J Int AIDS Soc       Date:  2016-03-01       Impact factor: 5.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.